Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 61 of 2459…endothelin receptor antagonists (ERA), and 33% on dual therapy (ERA + phosphodiesterase inhibitors). Only one case of pulmonary ede…
…Objective Buprenorphine is an atypical opioid with analgesic efficacy and a more favora…
…ECMO.Conclusions Heart failure is the leading cause of death in CAHD, followed by PH, with most deaths occurring within the first ye…
…ck associated with bupivacaine can delay recovery. In contrast, lidocaine, with its swift onset and intermediate duration, is an attracti…
…tients with late-onset MADD, no identified genotype, and taking sertraline.1 2 Treatment consists of withdrawal of sertraline. These repor…
…s-matched umbilical cord blood transplant, with ciclosporin and mycophenolate mofetil as GvHD prophylaxis. Post-transplant, he developed grade 3 skin…
…ched MS (n=257) and AQP4-IgG-positive NMOSD (n=58) evaluated at Mayo Clinic (1991–2025). Psychiatric diagnoses, timing relative to the firs…
… of lobeglitazone on renal disease progression in patients with type 2 diabetes mellitus using longitudinal real-world data.Design Retrospective cohort …
…discharge, or death). Antimicrobials considered for ST included levofloxacin, metronidazole, linezolid, clindamycin, fluconazole, ciprofloxa…